Trials / Active Not Recruiting
Active Not RecruitingNCT04960514
Prospective Decision Impact Trial of KidneyIntelX
A Prospective Decision Impact Trial of KidneyIntelX in Patients With Type 2 Diabetes and Existing Chronic Kidney Disease
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 2,000 (estimated)
- Sponsor
- Renalytix AI, Inc. · Industry
- Sex
- All
- Age
- 23 Years
- Healthy volunteers
- Not accepted
Summary
The current trial is designed to evaluate how the results of KidneyIntelX test / platform impacts on the clinical management of type 2 diabetes patients identified as increased risk for rapid kidney function decline within 5-years.
Conditions
- Diabetic Kidney Disease
- Chronic Kidney Disease Stage 1
- Chronic Kidney Disease Stage 2
- Chronic Kidney Disease, Stage 3 (Moderate)
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | KidneyIntelX | KidneyIntelX is a blood-based clinical diagnostic tool that assesses the risk of progressive kidney function decline in chronic kidney disease patients with type 2 diabetes. |
Timeline
- Start date
- 2021-11-22
- Primary completion
- 2023-12-01
- Completion
- 2026-12-01
- First posted
- 2021-07-14
- Last updated
- 2024-04-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04960514. Inclusion in this directory is not an endorsement.